This study was designed to document possible changes in bupivacaine ki
netics in rats after exposure to cigarette smoke. Rats (n = 15) were e
xposed to cigarette smoke (Borgwaldt type Hamburg II)for ten minutes p
er day during four days (C) or eight days (B); controls (A) were used
simultaneously without exposure to cigarette smoke. After bupivacaine
20 mg.kg(-1) ip at day 4 (C) or day 8 (B), blood was sampled (0.5 ml o
f blood collected by puncture at the retro-orbital sinus 0.25, 0.5, 1,
2, 4, 6 and 8 hours after administration) and bupivacaine and its mai
n metabolite i.e., desbutylbupivacaine (PPX) were determined by gas li
quid chromatography. The sensitivity of the method was 15 ng.ml(-1) an
d the reproductibility was <6%. Serum bupivacaine concentrations were
plotted against time and the pharmacokinetic variables were determined
assuming a two compartment open model: Cmax, Tmax were derived direct
ly from individual data. The beta phase elimination half-lives (T(1/2)
beta), the area under the serum concentration curve (AUC(0)(infinity))
, the total plasma clearance (CI) and the total volume of distribution
(Vd) were calculated. These variables were assessed according to non-
linear fitting method. Cigarette smoking exposure did not change the p
harmacokinetic variables of bupivacaine. However the pharmacokinetic p
arameters of PPX, Cmax (0.175 +/- 0.007 mu g.ml(-1), 0.119 +/- 0.014 m
u g.ml(-1) and 0.312 +/- 0.023 mu g.ml(-1), for groups A, B and C, res
pectively), AUC (0.170 +/- 0.006 mu g.ml(-1).hr(-1), 0.104 +/- 0.013 m
u g.ml(-1.)hr(-1) and 0.433 +/- 0.017 mu g.ml(-1.)hr(-1) for groups A,
B and C, respectively) and the ratio AUC PPX/ AUC bupivacaine (0.306
+/- 0.042, 0.153 +/- 0.021 and 0.660 +/- 0.054 for groups A, B and C,
respectively were higher (P < 0.0001) for group C. These results indic
ate an enzymatic induction after only short exposure to cigarette smok
ing and justify further studies to document possible variations of the
metabolism of bupivacaine induced by exposure to cigarette smoke in h
umans.